RE: Sp3 Mar 2023 10:28
The narrative of Vlad being a CEO not to trust or a bad CEO is NONSENSE i my view. He is not perfect, he has strengths and weaknesses, he had pulled off minor miracles, he has made mistakes. But who is perfect - I've never met or worked for a perfect CEO in my 30 tear career - but have worked for many successful ones.
Getting Hemogenyx to this point is evidence enough to have confidence IMHO - well funded, on the brink of IND and a move into the clinic with a fantastic drug candidate, and a potential firework in the shape of CBR.
He HAS tried to surround himself with people who have skillsets that compliment his. I was only watching last night, a video from 2014 when Hemogenxy won $250k in the 43North awards. Vlad was CSO at this point and Deena Malkina was CEO - someone who has experience in start-ups.
Mr India - I have 99.9% confidence that IND will be filed successfully. For me, getting it right first time and ensuring we are ready for Human trials is more important that the timing - I am confortable waiting weeks. In the event that the RNS does not land in the next few weeks, we'll get an update as part of the Final results.